3rd International Conference on Chemo and BioInformatics, Kragujevac, September 25-26. 2025. (pp. 595-598)
АУТОР(И) / AUTHOR(S): Petar B. Stanić, Biljana M. Šmit
Download Full Pdf 
DOI: 10.46793/ICCBIKG25.595S
САЖЕТАК / ABSTRACT:
The aim of this study is the in silico prediction and analysis of the physicochemical and pharmacological profile of a series of fused bicyclic hydantoin derivatives. The analysis estimates a favorable ADMET profile, high gastrointestinal absorbion and distribution capabilities. All compounds could be well metabolized in the body, with low to moderate clearance. With few exceptions, toxicological assessments do not predicts a possibility of toxic effects.
КЉУЧНЕ РЕЧИ / KEYWORDS:
hydantoins, fused bicyclic heterocycles, unnatural amino acids, ADMET
ПРОЈЕКАТ / ACKNOWLEDGEMENT:
This research is funded by the Ministry of Science, Technological Development and Innovation, Republic of Serbia, Grants: No. 451-03-136/2025-03/200378.
ЛИТЕРАТУРА / REFERENCES:
- S. H Cho, S.-H. Kim, D. Shin, Recent applications of hydantoin and thiohydantoin in medicinal chemistry, European Journal of Medicinal Chemistry, 164 (2019) 517-545.
- T. G. Castro, M. Melle-Franco, C.E.A. Sousa, A. Cavaco-Paulo, J.C. Marcos, Non-Canonical Amino Acids as Building Blocks for Peptidomimetics: Structure, Function, and Applications, Biomolecules, 12 (2023) 981.
- B. Šmit, R.Z. Pavlović, Three-step synthetic pathway to fused bicyclic hydantoins involving a selenocyclization step, Tetrahedron, 71 (2015) 1101-1108.
- L. Fu, S. Shi, J. Yi, N. Wang, Y. He, Z. Wu, J. Peng, Y. Deng, W. Wang, C. Wu, A. Lyu, X. Zeng, W. Zhao, T. Hou, D. Cao, ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support, Nucleic Acids Research, 52 (2024) W422–W431.